文献速递流行病学与生物统计医学教育与科研方法

焦虑筛查:美国预防服务工作组证据报告与系统综述

Anxiety Screening: Evidence Report and Systematic Review for the US Preventive Services Task Force.
PubMed 文献 · JAMA · 2023-01-01

本系统综述评估初级保健中焦虑筛查与治疗的获益与危害及筛查工具准确性。共纳入59篇文献,包括40项原始研究(N=275489)和19篇系统综述。证据不足以得出焦虑筛查项目获益或危害的结论,但治疗焦虑有益,GAD-2和GAD-7对广泛性焦虑障碍有足够准确性。

要点

  • 两项筛查研究发现焦虑筛查无获益。
  • GAD-7 cutoff为10时汇总灵敏度0.79(95%CI 0.69-0.94),特异度0.89(95%CI 0.83-0.94)。
  • 心理干预对初级保健焦虑患者焦虑症状严重度有小效应(SMD -0.41,95%CI -0.58至-0.23)。

核心结论

  • 证据不足以得出焦虑筛查项目获益或危害的结论,但明确证据表明治疗焦虑有益,且有限证据表明部分焦虑筛查工具检测广泛性焦虑障碍具有可接受的准确性。

研究设计与样本

  • 系统综述纳入59篇出版物,其中40项原始研究(N=275489)和19篇系统综述(包括约483项研究,N约81507)。
  • 检索MEDLINE、PsychINFO、Cochrane图书馆至2022年9月7日,并监测相关文献至2022年11月25日。
  • 两名研究者独立审查摘要和全文、独立评定研究质量。

主要发现

  • 两项筛查研究发现焦虑筛查无获益。
  • 仅GAD-2和GAD-7被超过1项研究评估;GAD-7 cutoff为10时,3项研究汇总灵敏度0.79(95%CI 0.69-0.94),特异度0.89(95%CI 0.83-0.94)。
  • 心理干预对初级保健焦虑患者焦虑症状严重度汇总标准化均数差为-0.41(95%CI -0.58至-0.23;10项RCT,n=2075;I²=40.2%),在一般成人人群中效应更大。
  • 其他工具和其他焦虑障碍的证据有限。

关键数值与推荐

  • GAD-7 cutoff为10时汇总灵敏度0.79(95%CI 0.69-0.94),特异度0.89(95%CI 0.83-0.94)。
  • 心理干预对初级保健焦虑患者焦虑症状严重度的汇总SMD为-0.41(95%CI -0.58至-0.23;10项RCT,n=2075;I²=40.2%)。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 证据不足以得出焦虑筛查项目获益或危害的结论。
  • 其他筛查工具和其他焦虑障碍的证据有限。
  • 仅GAD-2和GAD-7被超过1项研究评估。
  • 心理干预汇总分析异质性I²=40.2%。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

IMPORTANCE: Anxiety is commonly seen in primary care and associated with substantial burden. OBJECTIVE: To review the benefits and harms of screening and treatment for anxiety and the accuracy of instruments to detect anxiety among primary care patients. DATA SOURCES: MEDLINE, PsychINFO, Cochrane library through September 7, 2022; references of existing reviews; ongoing surveillance for relevant literature through November 25, 2022. STUDY SELECTION: English-language original studies and systematic reviews of screening or treatment compared with control conditions and test accuracy studies of a priori-selected screening instruments were included. Two investigators independently reviewed abstracts and full-text articles for inclusion. Two investigators independently rated study quality. DATA EXTRACTION AND SYNTHESIS: One investigator abstracted data; a second checked accuracy. Meta-analysis results were included from existing systematic reviews where available; meta-analyses were conducted on original research when evidence was sufficient. MAIN OUTCOMES AND MEASURES: Anxiety and depression outcomes; global quality of life and functioning; sensitivity and specificity of screening tools. RESULTS: Of the 59 publications included, 40 were original studies (N = 275 489) and 19 were systematic reviews (including ≈483 studies [N≈81 507]). Two screening studies found no benefit for screening for anxiety. Among test accuracy studies, only the Generalized Anxiety Disorder (GAD) GAD-2 and GAD-7 screening instruments were evaluated by more than 1 study. Both screening instruments had adequate accuracy for detecting generalized anxiety disorder (eg, across 3 studies the GAD-7 at a cutoff of 10 had a pooled sensitivity of 0.79 [95% CI, 0.69 to 0.94] and specificity of 0.89 [95% CI, 0.83 to 0.94]). Evidence was limited for other instruments and other anxiety disorders. A large body of evidence supported the benefit of treatment for anxiety. For example, psychological interventions were associated with a small pooled standardized mean difference of -0.41 in anxiety symptom severity in primary care patients with anxiety (95% CI, -0.58 to -0.23]; 10 RCTs [n = 2075]; I2 = 40.2%); larger effects were found in general adult populations. CONCLUSIONS AND RELEVANCE: Evidence was insufficient to draw conclusions about the benefits or harms of anxiety screening programs. However, clear evidence exists that treatment for anxiety is beneficial, and more limited evidence indicates that some anxiety screening instruments have acceptable accuracy to detect generalized anxiety disorder.

来源:JAMA,查看原文。版权归原作者所有。

引用

  1. O'Connor EA, Henninger ML, Perdue LA, et al. Anxiety Screening: Evidence Report and Systematic Review for the US Preventive Services Task Force. JAMA. 2023. PMID: 37338868. doi:10.1001/jama.2023.6369

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。